GPR40 deficiency worsens metabolic syndrome‐associated periodontitis in mice

Abstract

AbstractBackground and ObjectiveG protein‐coupled receptor 40 (GPR40) is a receptor for medium‐ and long‐chain free fatty acids (FFAs). GPR40 activation improves type 2 diabetes mellitus (T2DM), metabolic syndrome (MetS), and the complications of T2DM and MetS. Periodontitis, a common oral inflammatory disease initiated by periodontal pathogens, is another complication of T2DM and MetS. Since FFAs play a key role in the pathogenesis of MetS which exacerbates periodontal inflammation and GPR40 is a FFA receptor with anti‐inflammatory properties, it is important to define the role of GPR40 in MetS‐associated periodontitis.Materials and MethodsWe induced MetS and periodontitis by high‐fat diet and periodontal injection of lipopolysaccharide (LPS), respectively, in wild‐type and GPR40‐deficient mice and determined alveolar bone loss and periodontal inflammation using micro‐computed tomography, histology, and osteoclast staining. We also performed in vitro study to determine the role of GPR40 in the expression of proinflammatory genes.ResultsThe primary outcome of the study is that GPR40 deficiency increased alveolar bone loss and enhanced osteoclastogenesis in control mice and the mice with both MetS and periodontitis. GPR40 deficiency also augmented periodontal inflammation in control mice and the mice with both MetS and periodontitis. Furthermore, GPR40 deficiency led to increased plasma lipids and insulin resistance in control mice but had no effect on the metabolic parameters in mice with MetS alone. For mice with both MetS and periodontitis, GPR40 deficiency increased insulin resistance. Finally, in vitro studies with macrophages showed that deficiency or inhibition of GPR40 upregulated proinflammatory genes while activation of GPR40 downregulated proinflammatory gene expression stimulated synergistically by LPS and palmitic acid.ConclusionGPR40 deficiency worsens alveolar bone loss and periodontal inflammation in mice with both periodontitis and MetS, suggesting that GPR40 plays a favorable role in MetS‐associated periodontitis. Furthermore, GPR40 deficiency or inhibition in macrophages further upregulated proinflammatory and pro‐osteoclastogenic genes induced by LPS and palmitic acid, suggesting that GPR40 has anti‐inflammatory and anti‐osteoclastogenic properties.